Safety and activity of CLN-081 (TAS6417) in NSCLC with EGFR Exon 20 insertion mutations (Ins20).
暂无分享,去创建一个
M. Socinski | E. Smit | V. Lee | V. Velcheti | J. Wigginton | L. Zawel | J. Yang | J. Wrangle | R. Soo | A. Spira | D. Witter | Helena A. Yu | D. Nguyen | M. Koczywas | Z. Piotrowska | M. Clancy | Asher N Page | D. S. Tan | John M. Wrangle | H. Yu